In this era of technology, more than half of our days are spent sitting in front of computers or laptops, thus leaving little to no space for doing workouts. Similarly, the nature of our daily chores has also evolved to such a considerable extent that they hardly include any physical activity. Also, most of the people from today’s generation don’t want to do the physical work that our ancestors had to do in their time. Hence, these habits eventually lead to unhealthiness and raise some concerning health problems as well.
Therefore, to cope with this issue, researchers at Tokyo Medical and Dental University unveiled that they have discovered a drug that has the same effect as that of exercise on bones and muscles. Hence, we can say that the drug is a replica of exercise and will have the same effect on the body. The drug has been discovered by using a new type of drug screening system, and the compound that has been identified through this technique is called “locamidazole” for muscles and “aminoindazole” for bones. In short, it is known as “LAMZ”. It should be noted that the compound has been discovered as a result of proper research, and the findings of the research study have been published in the journal “Nature”.
We know that lack of physical activity leads to weakness in our muscles, and diseases like osteoporosis and sarcopenia are also becoming more common these days. Not only this, there are people who aren’t medically well due to certain diseases, so they can’t take the risk of doing exercise. Hence, this newly discovered drug is the answer to all such issues and is very efficient. The research study says that LAMZ is very effective in conforming to the growth of bone and muscle cells and also has the ability to help in the formation of osteoclasts.
It should be noted that the research was first tested on mice in a test trial and the findings were very optimistic. Mice were given locamidazole once a day for a total of 14 days by the Japanese researchers, and when the period ended, they detected the presence of that drug in the blood, muscles, and bones of the mice. Fortunately, there were no side effects detected.
To that end, Takehito Ono, who is the lead author of the research study, stated, “We were pleased to find that LAMZ-treated mice exhibited larger muscle fiber width, greater maximal muscle strength, a higher rate of bone formation, and lower bone resorption activity.”